Tobacco and inflammation effects in immunoexpression of hMSH2 and hMLH1 in epithelium of oral mucosa

Anticancer Research

Volumn 27, Issue 4 B, 2007, Pages 2433-2437

  Fernandes, Anacélia Mendes ^a   De Souza, Vânia Ribeiro Da Cunha ^a   Springer, Cornelis Robert Araújo ^a   Cardoso, Sérgio Vitorino ^b   Loyola, Adriano Mota ^b   Mesquita, Ricardo Alves ^a   Aguiar, Maria Cássia Ferreira ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

DNA; hMLH1; hMSH2; Inflammation; Mismatch repair; Normal tissue; Tobacco

Indexed keywords

NUCLEIC ACID BINDING PROTEIN; PROTEIN MSH1; PROTEIN MSH2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DEMOGRAPHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH MUCOSA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; TOBACCO;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOUTH MUCOSA; MUTS HOMOLOG 2 PROTEIN; NUCLEAR PROTEINS; SMOKING; STOMATITIS;

EID: 34547774259     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Modrich P: Mechanisms and biological effects of mismatch repair. Annu Rev Genet 25: 229-253, 1991.
2. Eshleman JR and Markowitz SD: Microsatellite instability in inherited and sporadic neoplasms. Curr Opin Oncol 7: 83-89, 2005.
3. Shin KH and Park JG: Microsatellite instability is associated with genetic alteration but not with low levels of expression of the human mismatch repair proteins hMSH2 and hMLH1. Eur J Cancer 36: 925-931, 2000.
4. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, Cavalieri RJ and Boland CR: Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104: 1535-1549, 1993.
5. Modrich P: Mismatch repair, genetic stability, and cancer. Science 266: 1959-1960, 1994.
6. Nakata B, Wang YQ, Yashiro M, Ohira M, Ishikawa T, Nishino H, Seki S and Hirakawa K: Negative hMSH2 protein expression in pancreatic carcinoma may predict a better prognosis of patients. Oncol Rep 10: 997-1000, 2003.
7. Brueckl WM, Limmert T, Brabletz T, Guenther K, Jung A, Hermann K, Wiest GH, Kirchner T, Hohenberger W, Hahn EG and Wein A: Mismatch repair deficiency in sporadic synchronous colorectal cancer. Anticancer Res 20: 4727-4732, 2000.
8. Peiro G, Diebold J, Mayr D, Baretton GB, Kimmig R, Schmidt M and Lohrs U: Prognostic relevance of hMLH1, hMSH2, and BAX protein expression in endometrial carcinoma. Mod Pathol 14: 777-783, 2001.
9. Aya M, Yashiro M, Nishioka N, Onoda N and Hirakawa K: Carcinogenesis in the remnant stomach following distal gastrectomy with billroth II reconstruction is associated with high-level microsatellite instability. Anticancer Res 26: 1403-1411, 2006.
10. Ueda H, Watanabe Y, Nakai H, Hemmi H, Koi M and Hoshiai H: Microsatellite status and immunohistochemical features of ovarian clear-cell carcinoma. Anticancer Res 25: 2785-2788, 2005.
11. Yeh CC, Lee C and Dahiya R: DNA mismatch repair enzyme activity and gene expression in prostate cancer. Biochem Biophys Res Commun 285: 409-413, 2001.
12. Lo Muzio L, Nocini P, Mignogna MD, Pannone G, Staibano S, Procaccini M, Rubini C, Fioroni M, Fanali S and Piattelli A: Immunocytochemical detection of hMSH2 and hMLH1 expression in oral melanoma. Anticancer Res 20: 741-748, 2000.
13. Liang SB, Furihata M, Takeuchi T, Sonobe H and Ohtsuki Y: Reduced human mismatch repair protein expression in the development of precancerous skin lesions to squamous cell carcinoma. Virchows Arch 439: 622-627, 2001.
14. Wei Q, Eicher SA, Guan Y, Cheng L, Xu J, Young LN, Saunders C, Jiang H, Hong WK, Spitz MR and Strom SS: Reduced expression of hMLH1 and hGTBP/hMSH6: a risk factor for head and neck cancer. Cancer Epidemiol Biomarkers Prev 7: 309-314, 1998.
15. Lo Muzio L, Nocini P, Mignogna MD, Pannone G, Staibano S, Procaccini M, Mariggio MA, Dolci M and De Rosa G: Immunocytochemical detection of hMSH2 and hMLH1 expression in oral SCC. Anticancer Res 19: 933-940, 1999.
16. Leach FS, Polyak K, Burrell M, Johnson KA, Hill D, Dunlop MG, Wyllie AH, Peltomaki P, de la Chapelle A, Hamilton SR, Kinzler KW and Vogelstein B: Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res 56: 235-240, 1996.
17. Plevova P, Sedlakova E, Zapletalova J, Krepelova A, Skypalova P and Kolar Z: Expression of the hMLH1 and hMSH2 proteins in normal tissues: relationship to cancer predisposition in hereditary non-polyposis colon cancer. Virchows Arch 446: 112-119, 2005.
18. Pimenta FJ, Pinheiro MD and Gomez RS: Expression of hMSH2 protein of the human DNA mismatch repair system in oral lichen planus. Int J Med Sci 1: 146-151, 2004.
19. Boffetta P, Mashberg A, Winkelmann R and Garfinkel L: Carcinogenic effect of tobacco smoking and alcohol drinking on anatomic sites of the oral cavity and oropharynx. Int J Cancer 52: 530-533, 1992.
20. Llewelyn J and Mitchell R: Smoking, alcohol and oral cancer in south east Scotland: a 10-year experience. Br J Oral Maxillofac Surg 32: 146-152, 1994.
21. Neville BW and Day TA: Oral cancer and precancerous lesions. CA Cancer J Clin 52: 195-215, 2002.
22. Coussens LM and Werb Z: Inflammation and cancer. Nature 420: 860-867, 2002.
23. Ayres M, Ayres-Jr M, Ayres DL and Santos AS: Bioestat 4.0 Aplicaçoes estatisticas nas áreas das ciências biológicas e medicas. Belém, Imprensa Oficial do Estado do Pará, 2005.
24. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, Moslein G, Baker SM, Liskay RM, Burgart LJ, Honchel R and Hailing KC: Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1: 4836-4840, 1996.
25. Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, Temple LK, Hsieh E, Hiruki T, Narod S, Bapat BV, Gallinger S and Redston M: Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 2: 1248-1255, 1999.
26. Stone JG, Robertson D and Houlston RS: Immunohistochemistry for MSH2 and MHL1: a method for identifying mismatch repair deficient colorectal cancer. J Clin Pathol 54: 484-487, 2001.
27. Shia J, Ellis NA and Klimstra DS: The utility of immunohistochemical detection of DNA mismatch repair gene proteins. Virchows Arch 445: 431-441, 2004.
28. Liu K, Huang H, Mukunyadzi P, Suen JY, Hanna E and Fan CY: Promoter hypermethylation: an important epigenetic mechanism for hMLH1 gene inactivation in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 126: 548-553, 2002.
29. Watson P, Ashwathnarayan R, Lynch HT and Roy HK: Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). Arch Intern Med 164: 2429-2431, 2004.
30. Siafakas NM and Tzortzaki EG: Few smokers develop COPD. Why? Respir Med 96: 615-624, 2002.
31. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 17: 539-545, 2001.
32. Chaiyarit P, Ma N, Hiraku Y, Pinlaor S, Yongvanit P, Jintakanon D, Murata M, Oikawa S and Kawanishi S: Nitrative and oxidative DNA damage in oral lichen planus in relation to human oral carcinogenesis. Cancer Sci 96: 553-559, 2005.
33. Chang CL, Marra G, Chauhan DP, Ha HT, Chang DK, Ricciardiello L, Randolph A, Carethers JM and Boland CR: Oxidative stress inactivates the human DNA mismatch repair system. Am J Physiol Cell Physiol 283: C148-154, 2002.
34. Cravo ML, Albuquerque CM, Salazar de Sousa L, Gloria LM, Chaves P, Dias Pereira A, Nobre Leitao C, Quina MG and Costa Mira F: Microsatellite instability in non-neoplastic mucosa of patients with ulcerative colitis: effect of folate supplementation. Am J Gastroenterol 93: 2060-2064, 1998.
35. Kullmann F, Widmann T, Kirner A, Justen HP, Wessinghage D, Dietmaier W, Ruschoff J, Gay S, Scholmerich J and Muller-Ladner U: Microsatellite analysis in rheumatoid arthritis synovial fibroblasts. Ann Rheum Dis 59: 386-389, 2000.